{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:25:53Z","timestamp":1787019953041,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"TSC Autism Center of Excellence Research Network"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tuberous Sclerosis Complex (TSC) is associated with a range of neuropsychiatric difficulties, appropriately termed TSC-Associated Neuropsychiatric Disorders (TAND). The objectives of the study were to analyze the rates of TAND symptoms in a cohort of patients seen at the TSC Center of Excellence at Cincinnati Children\u2019s Hospital and to identify clinically meaningful profiles based on TAND symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from the TAND Checklist was obtained from participants seen at the TSC Center of Excellence at Cincinnati Children\u2019s Hospital Medical Center from June 2015 to August 2018. Cluster and factor analyses for each TAND symptom were performed. Factor scores were then calculated for participants, and a K-means cluster analysis of these scores was used to empirically identify distinct overall TAND symptom profiles occurring in TSC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1545 checklists was completed for 668 participants (37% adults and 63% children). Approximately 90% of participants reported at least one TAND symptom with an average of 12 symptoms (out of 29). Symptom rates ranged between 5 and 60%. The most common symptoms were neuropsychologic symptoms. A seven-cluster and seven-factor solution were found to be optimal. K-means cluster analysis resulted in a seven-profile solution, ranging from low to high symptom burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study is the first to identify natural phenotypic profiles of TAND symptoms. Study of specific TAND subpopulations with shared profiles may facilitate better understanding of the underlying biology of TAND and better assessment of more targeted treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s11689-021-09408-8","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T09:03:56Z","timestamp":1639386236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Symptom rates and profile clustering in tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4703-2870","authenticated-orcid":false,"given":"Samuel","family":"Alperin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy A.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen D.","family":"Agricola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Stires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie K.","family":"Capal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"9408_CR1","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","volume":"351","author":"FJK O\u2019Callaghan","year":"1998","unstructured":"O\u2019Callaghan FJK, Shiell AW, Osborne JP, Martyn CN. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet. 1998;351:1490 Lancet Publishing Group; [cited 2020 Aug 24]Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/9605811\/.","journal-title":"Lancet"},{"key":"9408_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"P Curatolo","year":"2015","unstructured":"Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015;14:733\u201345.","journal-title":"Lancet Neurol"},{"key":"9408_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","volume":"52","author":"PJ de Vries","year":"2015","unstructured":"de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, et al. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist. Pediatr Neurol. 2015;52:25\u201335.","journal-title":"Pediatr Neurol"},{"key":"9408_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pediatrneurol.2018.10.011","volume":"91","author":"KE Mowrey","year":"2019","unstructured":"Mowrey KE, Ashfaq M, Pearson DA, Hashmi SS, Roberds SL, Farach LS, et al. The impact of psychiatric symptoms on tuberous sclerosis complex and utilization of mental health treatment. Pediatr Neurol. 2019;91:41\u20139.","journal-title":"Pediatr Neurol"},{"key":"9408_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:255\u201365.","journal-title":"Pediatr Neurol"},{"key":"9408_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13023-018-0901-8","volume":"13","author":"PJ de Vries","year":"2018","unstructured":"de Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, et al. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study. Orphanet J Rare Dis. 2018;13:157. https:\/\/doi.org\/10.1186\/s13023-018-0901-8.","journal-title":"Orphanet J Rare Dis"},{"key":"9408_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pediatrneurol.2014.10.006","volume":"52","author":"L Leclezio","year":"2015","unstructured":"Leclezio L, Jansen A, Whittemore VH, de Vries PJ. Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist. Pediatr Neurol. 2015;52:16\u201324.","journal-title":"Pediatr Neurol"},{"key":"9408_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pediatrneurol.2017.12.006","volume":"81","author":"L Leclezio","year":"2018","unstructured":"Leclezio L, Gardner-Lubbe S, de Vries PJ. Is it feasible to identify natural clusters of TSC-associated neuropsychiatric disorders (TAND)? Pediatr Neurol. 2018;81:38\u201344.","journal-title":"Pediatr Neurol"},{"key":"9408_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s11689-020-09327-0","volume":"12","author":"PJ de Vries","year":"2020","unstructured":"de Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, et al. Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project. J Neurodev Disord. 2020;12:24. https:\/\/doi.org\/10.1186\/s11689-020-09327-0.","journal-title":"J Neurodev Disord"},{"key":"9408_CR10","volume-title":"Identification of natural TSC-associated neuropsychiatric disorders (TAND) clusters","author":"L Leclezio","year":"2017","unstructured":"Leclezio L. Identification of natural TSC-associated neuropsychiatric disorders (TAND) clusters: University of Cape Town; 2017. Available from: http:\/\/hdl.handle.net\/11427\/27084"},{"key":"9408_CR11","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2018","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018. https:\/\/www.R-project.org. Available from: http:\/\/www.r-project.org"},{"key":"9408_CR12","volume-title":"Cluster: cluster analysis basics and extensions","author":"M Maechler","year":"2016","unstructured":"Maechler M, Rousseeus P, Struyf A, Hubert M, Hornik K. Cluster: cluster analysis basics and extensions; 2016."},{"key":"9408_CR13","volume-title":"Psych: procedures for personality and psychological research [internet]","author":"W Revelle","year":"2016","unstructured":"Revelle W. Psych: procedures for personality and psychological research [internet]. Evanston: Northwestern University; 2016. Available from: http:\/\/cran.r-project.org\/package=psych"},{"key":"9408_CR14","first-page":"57","volume":"2","author":"U Lorenzo-Seva","year":"2006","unstructured":"Lorenzo-Seva U, Berge J. Tucker\u2019s congruence coefficient as a meaningful index of factor similarity. Methodol Eur J Res Methods Behav Soc Sci. 2006;2:57\u201364.","journal-title":"Methodol Eur J Res Methods Behav Soc Sci"},{"key":"9408_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00787-006-0570-3","volume":"16","author":"PJ de Vries","year":"2007","unstructured":"de Vries PJ, Hunt A, Bolton PF. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry. 2007;16:16\u201324.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"9408_CR16","doi-asserted-by":"publisher","unstructured":"Adler LA, Faraone SV, Spencer TJ, Berglund P, Alperin S, Kessler RC. The structure of adult ADHD. Int J Methods Psychiatr Res. 2017;26(1):e1555. https:\/\/doi.org\/10.1002\/mpr.1555.","DOI":"10.1002\/mpr.1555"},{"key":"9408_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/dmcn.14055","volume":"61","author":"I Toldo","year":"2019","unstructured":"Toldo I, Brasson V, Miscioscia M, Pelizza MF, Manara R, Sartori S, et al. Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study. Dev Med Child Neurol England. 2019;61:168\u201373.","journal-title":"Dev Med Child Neurol England"},{"key":"9408_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","volume":"12","author":"JC Kingswood","year":"2017","unstructured":"Kingswood JC, d\u2019Aug\u00e8res GB, Belousova E, Ferreira JC, Carter T, Castellana R, et al. TuberOus SClerosis registry to increase disease awareness (TOSCA) - baseline data on 2093 patients. Orphanet J Rare Dis. 2017;12:2.","journal-title":"Orphanet J Rare Dis"},{"key":"9408_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13023-014-0182-9","volume":"9","author":"JC Kingswood","year":"2014","unstructured":"Kingswood JC, Bruzzi P, Curatolo P, de Vries PJ, Fladrowski C, Hertzberg C, et al. TOSCA - first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex. Orphanet J Rare Dis. 2014;9:182.","journal-title":"Orphanet J Rare Dis"},{"key":"9408_CR20","volume-title":"The voice of the patient: a report from the Tuberous Sclerosis Alliance\u2019s externally-led patient-focused drug development","author":"CN Ho","year":"2017","unstructured":"Ho CN, Rushing G, Valentine JE, Rosbeck KL, Roberds SL. The voice of the patient: a report from the Tuberous Sclerosis Alliance\u2019s externally-led patient-focused drug development; 2017. Available from: https:\/\/www.tsalliance.org\/wp-content\/uploads\/2018\/01\/Voice-of-the-Patient-Tuberous-Sclerosis-Alliance.pdf"},{"key":"9408_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","volume":"70","author":"JK Capal","year":"2017","unstructured":"Capal JK, Bernardino-Cuesta B, Horn PS, Murray D, Byars AW, Bing NM, et al. Influence of seizures on early development in tuberous sclerosis complex. Epilepsy Behav. 2017;70:245\u201352.","journal-title":"Epilepsy Behav"},{"key":"9408_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajmg.c.31637","volume":"178","author":"PJ de Vries","year":"2018","unstructured":"de Vries PJ, Wilde L, de Vries MC, Moavero R, Pearson DA, Curatolo P. A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). Am J Med Genet C: Semin Med Genet. 2018;178:309\u201320.","journal-title":"Am J Med Genet C: Semin Med Genet"},{"key":"9408_CR23","first-page":"603","volume":"11","author":"P De Vries","year":"2020","unstructured":"De Vries P, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, et al. Tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): new findings on age, sex, and genotype in relation to intellectual phenotype. Front Neurol. 2020;11:603.","journal-title":"Front Neurol"},{"key":"9408_CR24","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.celrep.2017.07.008","volume":"20","author":"JO Lipton","year":"2017","unstructured":"Lipton JO, Boyle LM, Yuan ED, Hochstrasser KJ, Chifamba FF, Nathan A, et al. Aberrant proteostasis of BMAL1 underlies circadian abnormalities in a paradigmatic mTOR-opathy. Cell Rep. 2017;20:868\u201380.","journal-title":"Cell Rep"},{"key":"9408_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jsmc.2021.02.011","volume":"16","author":"T Wu","year":"2021","unstructured":"Wu T, Avidan AY, Engel JJ. Sleep and epilepsy, clinical spectrum and updated review. Sleep Med Clin. 2021;16:389\u2013408.","journal-title":"Sleep Med Clin"},{"key":"9408_CR26","volume-title":"Empowering families through technology: a mobile-health project to reduce the TAND identification and treatment gap (TANDem) [internet]","author":"PJ de Vries","year":"2019","unstructured":"de Vries PJ, Jansen A. Empowering families through technology: a mobile-health project to reduce the TAND identification and treatment gap (TANDem) [internet]; 2019. Available from: https:\/\/www.orpha.net\/data\/prj\/BE\/Research-project_KBF_TSC.pdf"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-021-09408-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-021-09408-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-021-09408-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T09:04:57Z","timestamp":1639386297000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-021-09408-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9408"],"URL":"https:\/\/doi.org\/10.1186\/s11689-021-09408-8","relation":{},"ISSN":["1866-1947","1866-1955"],"issn-type":[{"value":"1866-1947","type":"print"},{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"9 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CCHMC Institutional Review Board approved the protocol through which this research was performed. Informed consent was obtained from adult participants and from parents or guardians for participants under 18 years of age. Assent was provided by participants when able per institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Samuel Alperin, Karen D. Agricola, Gabrielle Stires, and Paul S. Horn have no disclosures. Darcy Krueger reports consulting fees and\/or research support from Novartis Pharmaceuticals, TS Alliance, Druggability Technologies, Greenwich Biosciences, and Marinus Pharmaceuticals. Dr. Krueger also has received speaking fees from Novartis Pharmaceuticals and Greenwich Biosciences. David N. Franz reports travel support and honoraria from Novartis (more than 2 years ago). His employer has also received support for clinical trials and consulting work from Novartis (more than 2 years ago). Jamie K. Capal receives research support from Roche.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}